Middle East & Africa Parenteral Nutrition Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins and Minerals) and End User (Hospitals, Clinics, and Others)

No. of Pages: 84    |    Report Code: BMIRE00030469    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Parenteral Nutrition Market
Free Sample Buy Now

The Middle East & Africa parenteral nutrition market was valued at US$ 208.88 million in 2022 and is expected to reach US$ 288.90 million by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030.

Innovation in Formulations of Nutrition Products Bolster Middle East & Africa Parenteral Nutrition Market



There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macronutrient and micronutrient formulations of parenteral nutrition and their applications vary based on the type of disease, including cancer and gastrointestinal diseases.

Significant developments in Innovative formulations bring in a new era of nutritional solutions that are designed to meet all individual demands as well as the medical conditions of each patient. This level of personalization improves patient outcomes in addition to increasing the effectiveness of parenteral nutrition. Formulation innovations enable the market to fully meet the unique nutritional needs of different patients, from newborns and older adults to people with certain medical conditions. For example, the emergence of lipid-based emulsions with improved stability and bioavailability is changing the face of intravenous nourishment, especially for the treatment of premature infants. Additionally, the inherent risks of problems and side effects that have traditionally been connected to conventional nutritional solutions are reduced because of these formulation innovations. The industry is positioned for exceptional growth and long-term success because of its dual benefits of promoting the adoption of parenteral nutrition within the healthcare ecosystem and improving patient care. Thus, innovation in the formulations of nutrition products is anticipated to create opportunities for the market growth during the forecast period. Thus, the innovation in formulations of nutrition products act as future growth trends in the parenteral medical nutrition market.

Middle East & Africa Parenteral Nutrition Market Overview



According to a mid-2020 report from the General Authority for Statistics, ~25,000 babies are born prematurely in Saudi Arabia yearly. The premature babies are placed in incubators for 30-60 days, which can cost government hospitals or insurance companies ~US$ 16,000 (SAR 60,000) for individual treatment and specialized care. If babies are required to be kept in incubation for longer periods, it can cost ~US$ 26,667 (SAR 100,000). In such a scenario, nutritional support is crucial to attain a similar growth rate compared to babies of the same age, and it can be provided through enteral or parenteral ways. Most immature preterm babies depend on parenteral nutrition, especially for babies born with low birth weight (<1,500g). Such babies are not offered enteral feeding due to the severity of medical problems associated with prematurity (such as underdeveloped major organs, infections, and feeding intolerance). The Ministry of Health (MoH) in the country operates 287 hospitals. According to the data published by the MoH, 236 hospitals currently provide home healthcare, of which some either incorporate either home enteral nutrition (HEN) or home parenteral nutrition (HPN), or both services. Therefore, the demand for parenteral nutrition is anticipated to grow rapidly in Saudi Arabia due to the rising number of premature births and increasing government efforts to support and spread awareness among the population regarding parenteral nutrients.

Middle East & Africa  Revenue and Forecast to 2030 (US$ Million)



Middle East & Africa Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
Get more information on this report

Middle East & Africa Parenteral Nutrition Strategic Insights

Strategic insights for the Middle East & Africa Parenteral Nutrition provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-parenteral-nutrition-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Parenteral Nutrition Report Scope

Report Attribute Details
Market size in 2022 US$ 208.88 Million
Market Size by 2030 US$ 288.90 Million
Global CAGR (2022 - 2030) 4.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Nutrient Type
  • Single Dose Amino Acid Solution
  • Parenteral Lipid Emulsion
  • Carbohydrates
  • Trace Elements
  • Vitamins and Minerals
By End User
  • Hospitals
  • Clinics
Regions and Countries Covered Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Aculife Healthcare Pvt Ltd
  • Vifor Pharma Management AG
    		•
    Get more information on this report

    Middle East & Africa Parenteral Nutrition Regional Insights

    The geographic scope of the Middle East & Africa Parenteral Nutrition refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/middle-east-and-africa-parenteral-nutrition-market-geography.webp
    Get more information on this report

    Middle East & Africa  Segmentation



    The Middle East & Africa parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Middle East & Africa is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

    By end user, the Middle East & Africa is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

    Based on country, the Middle East & Africa is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa share in 2022.

    ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Middle East & Africa .

    Identical Market Reports with other Region/Countries

    The List of Companies - Middle East & Africa Parenteral Nutrition Market

    1. ICU Medical Inc
    2. Grifols SA
    3. Pfizer Inc
    4. Otsuka Pharmaceuticals Co Ltd
    5. Baxter International Inc
    6. B Braun SE
    7. Fresenius Kabi AG
    8. Aculife Healthcare Pvt Ltd 
    9. Vifor Pharma Management AG

    Frequently Asked Questions
    How big is the Middle East & Africa Parenteral Nutrition Market?

    The Middle East & Africa Parenteral Nutrition Market is valued at US$ 208.88 Million in 2022, it is projected to reach US$ 288.90 Million by 2030.

    What is the CAGR for Middle East & Africa Parenteral Nutrition Market by (2022 - 2030)?

    As per our report Middle East & Africa Parenteral Nutrition Market, the market size is valued at US$ 208.88 Million in 2022, projecting it to reach US$ 288.90 Million by 2030. This translates to a CAGR of approximately 4.1% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Parenteral Nutrition Market report typically cover these key segments-

  • Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, Vitamins and Minerals)
  • End User (Hospitals, Clinics)

    • What is the historic period, base year, and forecast period taken for Middle East & Africa Parenteral Nutrition Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Parenteral Nutrition Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in Middle East & Africa Parenteral Nutrition Market?

    The Middle East & Africa Parenteral Nutrition Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Aculife Healthcare Pvt Ltd
  • Vifor Pharma Management AG
    • Who should buy this report?

    The Middle East & Africa Parenteral Nutrition Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Parenteral Nutrition Market value chain can benefit from the information contained in a comprehensive market report.

    middle-east-and-africa-parenteral-nutrition-market